Given that RhoC GTPase has been shown to be a key driver of IBC metastasis in in vivo models26 and it is differentially expressed between IBC and nIBC tumors across studies16, 17, 19, we hypothesized that RhoC plays a role in the enhanced migration response of IBC to the MCM. This evidence concerns the gene RHOC and inflammatory breast carcinoma.